Myocarditis Risk From COVID-19 Vaccines Up To 3 times Higher From Moderna Than Pfizer: Study

  • Researchers pulled data from approximately 3 million people in British Columbia, Canada, and used participants over the age of 18 who were hospitalized for myocarditis, pericarditis, or myopericarditis within 21 days after having received a second Pfizer or Moderna between Jan. 1, 2021, and Sept. 9, 2021.
  • The study excluded participants that had experienced myocarditis or pericarditis within one year before receiving the second dose of the COVID-19 vaccine.
  • “Within 21 days of the second dose, there were a total of 59 myocarditis cases, 21 after Pfizer and 31 after Moderna; and there were a total of 41 pericarditis cases: 21 after Pfizer and 20 after Moderna,” the study reads.
Click to read full article Go back home

Sign Up for Our Newsletter

Join our list!

Sign up here to get our daily newsletter with the top trending headlines.